Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMEDNYSEAMERICAN:BZMNYSE:CDI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMEDAmedisys$98.03-0.1%$95.16$82.15▼$98.95$3.22B0.94420,309 shs391,201 shsBZMBlackRock Maryland Municipal Bond Trust$15.00-2.3%$15.00$13.09▼$17.10N/AN/A3,521 shs21,400 shsCDICDI$8.22$0.00$4.84▼$9.65N/AN/A81,650 shsN/AThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMEDAmedisys-0.05%+0.14%+4.30%+5.75%+6.55%BZMBlackRock Maryland Municipal Bond Trust0.00%0.00%0.00%0.00%0.00%CDICDI0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMEDAmedisys3.3589 of 5 stars1.13.00.05.03.01.71.3BZMBlackRock Maryland Municipal Bond TrustN/AN/AN/AN/AN/AN/AN/AN/ACDICDIN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMEDAmedisys 2.20Hold$100.752.77% UpsideBZMBlackRock Maryland Municipal Bond Trust 0.00N/AN/AN/ACDICDI 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest DP3D, AMED, BZM, and CDI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/16/2025AMEDAmedisysRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$100.00 ➝ $100.00(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMEDAmedisys$2.35B1.37$6.23 per share15.74$36.03 per share2.72BZMBlackRock Maryland Municipal Bond TrustN/AN/AN/AN/AN/AN/ACDICDIN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMEDAmedisys$43.23M$2.7136.1720.251.333.79%12.52%7.01%7/23/2025 (Estimated)BZMBlackRock Maryland Municipal Bond TrustN/AN/A0.00∞N/AN/AN/AN/AN/ACDICDIN/AN/A0.00∞N/AN/AN/AN/AN/ALatest DP3D, AMED, BZM, and CDI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/23/2025Q2 2025AMEDAmedisys$1.39N/AN/AN/A$614.61 millionN/A4/23/2025Q1 2025AMEDAmedisys$1.13$1.25+$0.12$1.84$597.43 million$594.78 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMEDAmedisysN/AN/AN/AN/AN/ABZMBlackRock Maryland Municipal Bond Trust$0.573.80%N/AN/AN/ACDICDIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMEDAmedisys0.271.291.29BZMBlackRock Maryland Municipal Bond TrustN/AN/AN/ACDICDIN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMEDAmedisys94.36%BZMBlackRock Maryland Municipal Bond TrustN/ACDICDI35.88%Insider OwnershipCompanyInsider OwnershipAMEDAmedisys2.10%BZMBlackRock Maryland Municipal Bond TrustN/ACDICDI8.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMEDAmedisys19,00032.82 million32.13 millionOptionableBZMBlackRock Maryland Municipal Bond Trust60N/AN/ANot OptionableCDICDIN/AN/AN/ANot OptionableDP3D, AMED, BZM, and CDI HeadlinesRecent News About These CompaniesNew Orleans Horse Betting to Resume in November2 hours ago | covers.comCTailored TB treatment based on disease severity may improve patient outcomes2 hours ago | msn.comFecal Microbiota Transplantation Could Be First-Line Therapy for C. DifficileJune 25 at 4:26 PM | msn.comDeal approved to keep horses racing at Fair GroundsJune 25 at 4:26 PM | neworleanscitybusiness.comNFair Grounds Meet to Move Forward After Dates ApprovedJune 24 at 11:47 PM | bloodhorse.comBDates For Fair Grounds Meet Officially SetJune 24 at 11:47 PM | msn.comLouisiana Commission Awards Fair Grounds Dates After CDI Rescinds Threat To Close TrackJune 24 at 11:47 PM | thoroughbreddailynews.comTFecal Microbiota Transplant as good as Vancomycin as Initial Treatment for C. diff, Study FindsJune 23, 2025 | medicaldialogues.inMStudy highlights optimal strategies for fecal transplantation in C diff patientsJune 23, 2025 | cidrap.umn.eduCBethan Williams, from Cardiff, wins national CDI awardJune 21, 2025 | msn.comCareers Adviser Wins National Award for Championing Neurodiverse SupportJune 21, 2025 | businessnewswales.comBFair Grounds Wins Game of Chicken with Churchill Downs Inc.June 19, 2025 | msn.comChandra Asri’s investment arm to raise over 2.3 trillion rupiah in IPOJune 19, 2025 | businesstimes.com.sgBWilkie: Fair Grounds Without CDI? What NOLA Can Learn From MarylandJune 18, 2025 | msn.com'We're Encouraged': Louisiana Commission Schedules Meeting With Fair Grounds Race Dates On AgendaJune 17, 2025 | msn.comO’Donnell: Could New Orleans spirit have saved Arlington Park?June 17, 2025 | dailyherald.comDAgreement Reached, Fair Grounds Will Hold 2025-26 MeetJune 17, 2025 | thoroughbreddailynews.comTCDI targets "troubling" patterns in State Farm wildfire claimsJune 17, 2025 | insurancebusinessmag.comIFair Grounds Racing to Continue After Agreement ReachedJune 17, 2025 | bloodhorse.comBDeal saves Fair Grounds horse racing in New Orleans for upcoming seasonJune 17, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDP3D, AMED, BZM, and CDI Company DescriptionsAmedisys NASDAQ:AMED$98.03 -0.05 (-0.05%) Closing price 06/26/2025 04:00 PM EasternExtended Trading$98.79 +0.76 (+0.77%) As of 06/26/2025 05:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.BlackRock Maryland Municipal Bond Trust NYSEAMERICAN:BZM$15.00 -0.35 (-2.28%) As of 04/16/2021BlackRock Maryland Municipal Bond Trust is a closed ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC. The fund invests in fixed income markets of United States. It primarily invests in the investment grade municipal bonds exempt from federal income taxes and Maryland personal income taxes. BlackRock Maryland Municipal Bond Trust was formed on April 30, 2002 and is domiciled in United States.CDI NYSE:CDICDI Corp. provides engineering, information technology and staffing solutions. The Company operates in three segments: Global Engineering and Technology Solutions (GETS), Professional Staffing Services (PSS) and Management Recruiters International (MRI). It provides staffing services through its MRINetwork of franchisees. The GETS segment provides engineering and information technology solutions that involve the production of deliverable work products or services performed at its facility or at a customer's facility. The PSS segment provides technical and professional personnel for discrete periods of time to augment the customer's workforce in times of project, seasonal, peak period or business cycle needs. The MRI segment is a global franchisor that does business as MRINetwork and provides the use of its trademarks, business systems and training and support services to its franchisees. It serves the oil, gas and chemicals, aerospace and industrial equipment, and hi-tech industries. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside Is IBM’s AI Transformation Powering a Sustained Rally? Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst Amazon: Why Some Are Growing Bearish, and Why They’re Wrong ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside Astera Labs: AI Infrastructure Play With Significant Growth Ahead Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
